Japan vs Kenya: The number of people with susceptibility test result for rifampicin
Japan
62.2
in 2021
Kenya
63.13
in 2021
Japan rank
108th
Kenya rank
107th
The number of people with susceptibility test result for rifampicin over time
- Japan
- Kenya
How they compare
Kenya currently reports 63.13 against 62.2 in Japan, a difference of 0.93.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Japan ahead.
Japan ranks 108th and Kenya ranks 107th of 146 countries.
Across the 2 decades both report, Japan averaged higher in 1 and Kenya in 1.
Head to head by decade
| Decade | Japan | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.84 | 68.03 | 3.81 | Japan |
| 2020s | 63.07 | 74.02 | 10.95 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Japan or Kenya?
- Kenya, at 63.13 against 62.2 in Japan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Japan and Kenya?
- 0.93, with Kenya ahead.
- How many years of comparable data are there for Japan and Kenya?
- 5 years are reported by both, from 2017 to 2021.
- How do Japan and Kenya rank globally for the number of people with susceptibility test result for rifampicin?
- Japan ranks 108th and Kenya ranks 107th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.